© Globe Newswire
06.01.2026
ACON
LISTED
NASDAQ
Aclarion Announces First Patient Enrollments at Two Additional CLARITY Trial Sites and Provides Guidance on Expected Availability of Initial Data
News Preview
Aclarion Announces First Patient Enrollments at Two Additional CLARITY Trial Sites and Provides Guidance on Expected Availability of Initial Data...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.01.2026
APGE
LISTED
NASDAQ
Apogee Therapeutics Announces Positive Interim Results from Phase 1b Trial of Zumilokibart (APG777), its Potentially Best-in-Class Anti-IL-13 Antibody, in Patients with Mild-to-Moderate Asthma and Highlights 2026 Anticipated Milestones and Outlook
News Preview
Phase 1b interim results of zumilokibart (APG777) in asthma demonstrated rapid and durable suppression of FeNO (key biomarker of Type 2 inflammation) through 16 weeks for all patients - Suppression of FeNO through 32 weeks for patients with available follow up - Results reinforce continued development in asthma testing every 3- or 6-month dosing...
Themefolio
Profiler
Peergroup
© EQS Newswire
06.01.2026
AAQ1
LISTED
XETR
aap platziert zu EUR 1,34 erfolgreich eine 5,7% Kapitalerhöhung aus genehmigtem Kapital unter Ausschluss des Bezugsrechts
News Preview
Der Liquiditätszufluss wird die Investitionen in die Zulassung der innovativen antibakteriellen Implantat-Technologie stärken
Die aap Implantate AG („aap“ oder „Gesellschaft“) konnte erfolgreich die am 4. Dezember 2025 angekündigte 5,7% Kapitalerhöhung unter Ausschluss des Bezugsrechts mit einem Platzierungspreis von EUR 1,34 abschließen. Der Gesel......
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© ACCESS Newswire
06.01.2026
MDCE
LISTED
OTC
Medical Care Technologies Inc. (OTC Pink:MDCE) Announces Attendance at CES 2026 in Las Vegas
News Preview
"MDCE leadership engages directly with cutting-edge innovators at CES 2026 as MDCE advances its AI wellness application portfolio." LAS VEGAS, NEVADA / ACCESS Newswire / January 6, 2026 / Medical Care Technologies Inc. (OTC Pink:MDCE) is pleased to announce that the CEO and members of the Company's tech team are currently attending the Co...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© ACCESS Newswire
06.01.2026
JAGX
LISTED
NASDAQ
Article About Groundbreaking Results from Study of Jaguar Health's Crofelemer for Treatment of Intestinal Failure Featured in United Arab Emirates Healthcare Publication
News Preview
Article discusses results demonstrating parenteral support (PS) reduction ranging from 12 to 37% in ongoing proof-of-concept study of crofelemer in pediatric patients with intestinal failureAssociated with significant toxicities to patients, PS has a lethal natural history, and PS reduction can potentially extend and save lives SAN FRANCISCO, CA /...
Themefolio
Profiler
Peergroup
© ACCESS Newswire
06.01.2026
STEK
LISTED
OTC
Stemtech Corporation Appoints Dr. Lizette Leos, MD To Chief Scientific Officer (CSO)
News Preview
NAPLES, FL / ACCESS Newswire / January 6, 2026 / Stemtech Corporation, the global leader and pioneer in stem cell nutrition, is proud to appoint Dr. Lizette Leos, MD to Chief Scientific Officer. (Stemtech Corporation - OTCQB:STEK)Dr. Lizette Betsabe Leos Lopez, MD President & COO, John W. Meyer stated "Dr. Leos has been with Stemtech sin...
Themefolio
Profiler
Peergroup
© ACCESS Newswire
06.01.2026
RGNT
LISTED
XASE
Regentis' GelrinC Establishes Long-Term Durability of Cartilage Repair Through Quantitative MOCART Evaluation
News Preview
Marks a world-first as Regentis uses MOCART, a quantitative standard to measure regeneration of cartilage in a clinical trial, as a predefined endpointNew peer-reviewed data published in the scientific journal Cartilage uses the complete set of follow-up data from GelrinC's Phase II study, which establishes GelrinC as a leader in long-term durable...
Themefolio
Profiler
Peergroup
© ACCESS Newswire
06.01.2026
IGC
LISTED
XASE
IGC Pharma Aligns Fiscal Year with Calendar Year to Enhance U.S. Investor Transparency and Comparability
News Preview
POTOMAC, MD / ACCESS Newswire / January 6, 2026 / IGC Pharma, Inc. ("IGC Pharma," "IGC," or the "Company") (NYSE American:IGC), a clinical-stage pharmaceutical company leveraging Artificial Intelligence (AI) to develop innovative treatments for Alzheimer's disease, today announced that its Board of Directors has approv...
Themefolio
Profiler
Peergroup
© EQS Newswire
06.01.2026
NWRN
LISTED
SIX
Newron erweitert IP-Portfolio mit neuem EU-Stoffpatent für Evenamide
News Preview
Newron erweitert IP-Portfolio mit neuem EU-Stoffpatent für Evenamide
EP4615820 – „Kristalline Formen von Evenamide“ wird voraussichtlich die Exklusivität für das Produkt in der EU bis 2044 verlängern
Evenamide wird derzeit von Newron im Rahmen des globalen Phase-III-Programms ENIGMA-TRS entwickelt, an dem mindestens 1000 Schizophrenie-Patienten ......
Themefolio
Profiler
Peergroup
© EQS Newswire
06.01.2026
NWRN
LISTED
SIX
Newron Further Expands Intellectual Property Portfolio for Evenamide with New EU Composition of Matter Patent
News Preview
Newron Further Expands Intellectual Property Portfolio for Evenamide with New EU Composition of Matter Patent
EP4615820 – “Crystalline Forms of Evenamide” is expected to extend asset exclusivity in EU into 2044
Evenamide is currently being investigated in Newron’s global ENIGMA-TRS Phase III development program, enrolling at least 1,000 schizoph......
Themefolio
Profiler
Peergroup
© ACCESS Newswire
06.01.2026
CBDL
LISTED
OTC
CBD Life Sciences Inc. (CBDL) Expands Into JFK Airport Through Landmark Mother Earth Juice Bar Partnership in New York
News Preview
With the global pain management market projected to exceed $110 billion by 2030 and hemp-derived topical products continuing to post double-digit annual growth, CBD Life Sciences is accelerating its expansion into premium, high-traffic retail environments nationwide. SCOTTSDALE, ARIZONA / ACCESS Newswire / January 6, 2026 / CBD Life Sciences Inc. (...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.01.2026
IDIA
LISTED
SIX
Idorsia initiates a proof-of-concept trial with its oral first-in-class selective CCR6 antagonist
News Preview
Allschwil, Switzerland – January 6, 2026Idorsia Ltd (SIX: IDIA) announces the initiation of a Phase 2 proof-of-concept trial evaluating IDOR-1117-2520 for participants with moderate-to-severe psoriasis. IDOR-1117-2520 is Idorsia’s first-in-class, oral, selective CCR6 receptor antagonist designed to block the CCR6/CCL20 axis and prevent the migratio...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Globe Newswire
06.01.2026
FAGR
LISTED
EURONEXT
Fagron announces the completion of Purifarma
News Preview
Regulated information - inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 6 January 2026 – 7:00 AM CET...
Themefolio
Profiler
Peergroup
© ACCESS Newswire
06.01.2026
LOBE
LISTED
CSE
Lobe Sciences Reports Fiscal 2025 Results and Highlights Strategic Transformation Following Leadership Transition
News Preview
VANCOUVER, BRITISH COLUMBIA / ACCESS Newswire / January 6, 2026 / Lobe Sciences Ltd. (CSE:LOBE)(OTCQB:LOBEF)(FWB:LOBE.F) ("Lobe" or the "Company"), a biopharmaceutical company advancing programs in diseases with unmet medical needs, today reported audited financial results for the fiscal year ended August 31, 2025 ("FY2025&...
Themefolio
Profiler
Peergroup
© BusinessWire
06.01.2026
NTRA
LISTED
NASDAQ
Natera Presents Updated Analyses From ALTAIR Clinical Trial at ASCO GI
News Preview
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced that new data from the ALTAIR trial will be presented at the 2026 American Society of Clinical Oncology Gastrointestinal Cancers Symposium (ASCO GI), taking place January 8-10, 2026.
A new analysis will be presented from the randomized, double-b...
Themefolio
Profiler
Peergroup
© Globe Newswire
06.01.2026
BIIB
LISTED
NASDAQ
Biologics License Application for Subcutaneous Formulation of “LEQEMBI®” (lecanemab) for the Treatment of Early Alzheimer’s Disease Accepted in China
News Preview
If approved, lecanemab may become the first and only anti-amyloid treatment in China to offer an at-home injection from the initiation of treatment for this progressive, relentless disease If approved, lecanemab may become the first and only anti-amyloid treatment in China to offer an at-home injection from the initiation of treatment for this prog...
Themefolio
Profiler
Peergroup
© PR Newswire
06.01.2026
1952
LISTED
HKSE
Everest Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference
News Preview
SHANGHAI, Jan. 6, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced that Ian Woo, President and Chief Financial Officer, will present a company update and tha...
Themefolio
Profiler
Peergroup
© PR Newswire
06.01.2026
1952
LISTED
HKSE
Everest Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference
News Preview
SHANGHAI, Jan. 5, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced that Ian Woo, President and Chief Financial Officer, will present a company update and tha...
Themefolio
Profiler
Peergroup
© BusinessWire
06.01.2026
QURE
LISTED
NASDAQ
QURE Investigation: Investors Encouraged to Contact Kirby McInerney LLP
News Preview
The law firm of Kirby McInerney LLP reminds investors its investigation on behalf of uniQure N.V. (“uniQure” or the “Company”) (NASDAQ:QURE) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws or other unlawful business practices.
[LEARN MORE ABOUT THE INVESTIGATION]
Wh...
Themefolio
Profiler
Peergroup
© BusinessWire
06.01.2026
ALVO
LISTED
ICE
ALVO Investigation: Investors Encouraged to Contact Kirby McInerney LLP
News Preview
The law firm of Kirby McInerney LLP reminds investors its investigation on behalf of Alvotech (“Alvotech” or the “Company”) (NASDAQ:ALVO) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws or other unlawful business practices.
[LEARN MORE ABOUT THE INVESTIGATION]
What...
Themefolio
Profiler
Peergroup
© Newsfile
05.01.2026
DOSE
LISTED
CSE
Rapid Dose Announces Payment in Shares for Quarterly Interest on Secured Debt
News Preview
Burlington, Ontario--(Newsfile Corp. - January 5, 2026) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") announced today that pursuant to the terms of its amended and restated secured convertible notes dated December 1, 2025 (the "Notes"), the Company intends to issue common shares ("Common Shares") in satisfaction of...
Themefolio
Profiler
Peergroup
© PR Newswire
05.01.2026
MDT
LISTED
NYSE
Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference
News Preview
GALWAY, Ireland, Jan. 5, 2026 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the 44th annual J.P. Morgan healthcare conference on Monday, January 12, 2026.Geoff Martha, Medtronic chairman and chief executive officer, will make a formal presentation and answer questions on...
Themefolio
Profiler
Peergroup
© PR Newswire
05.01.2026
VEEV
LISTED
NYSE
Veeva Announces Share Repurchase Program
News Preview
PLEASANTON, Calif., Jan. 5, 2026 /PRNewswire/ -- Veeva Systems Inc. (NYSE: VEEV), a leading provider of industry cloud solutions for the global life sciences industry, today announced that its Board of Directors approved a share repurchase program with authorization to purchase up to $2 billion of shares of its Class A common stock....
Themefolio
Profiler
Peergroup
© BusinessWire
05.01.2026
MTD
LISTED
NYSE
Mettler-Toledo International Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference
News Preview
Mettler-Toledo International Inc. (NYSE: MTD) today announced it will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, California on Monday, January 12, 2026 at 4:30 p.m. Pacific Standard Time. A live webcast of the presentation will be available on the Company’s investor relations website at investor.mt.com.
METTLE...
Themefolio
Profiler
Peergroup
© BusinessWire
05.01.2026
TVTX
LISTED
NASDAQ
Travere Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
News Preview
Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that Eric Dube, Ph.D., president and chief executive officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026, at 4:30 p.m. PT.
A live webcast of the presentation will be accessible on the Investor page of Travere’s website at ir.travere.com/e...
Themefolio
Profiler
Peergroup
© PR Newswire
05.01.2026
ABT
LISTED
NYSE
Abbott hosts conference call for fourth-quarter earnings
News Preview
ABBOTT PARK, Ill., Jan. 5, 2026 /PRNewswire/ -- Abbott (NYSE: ABT) will announce its fourth-quarter 2025 financial results on Thursday, Jan. 22, before the market opens.
The announcement will be followed by a live webcast of the earnings conference call at 8 a.m. Central time (9 a.m. Eastern) and will be accessible through Abbott's Investor Relati...
Themefolio
Profiler
Peergroup
© PR Newswire
05.01.2026
DHR
LISTED
NYSE
Danaher to Present at J.P. Morgan Healthcare Conference
News Preview
WASHINGTON, Jan. 5, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that its President and Chief Executive Officer, Rainer M. Blair, will be presenting at the J.P. Morgan Healthcare Conference in San Francisco, California on Tuesday, January 13, 2026 at 11:15 a.m. PT. The event will be simultaneously webcast and can be accessed on t...
Themefolio
Profiler
Peergroup
© BusinessWire
05.01.2026
CNMD
LISTED
NYSE
CONMED Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference
News Preview
CONMED Corporation (NYSE: CNMD) today announced that Patrick J. Beyer, President and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will present at the 44th Annual J.P. Morgan Healthcare Conference at 3:00 p.m. PT (6:00 p.m. ET) on Monday, January 12, 2026 in San Francisco, CA.
A live audio web...
Themefolio
Profiler
Peergroup
© BusinessWire
05.01.2026
CNMD
LISTED
NYSE
CONMED Corporation to Announce Fourth Quarter 2025 Financial Results on January 28, 2026
News Preview
CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the fourth quarter 2025 after the market close on Wednesday, January 28, 2026. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.
To participate in the conference call via telephone, please click here...
Themefolio
Profiler
Peergroup
© BusinessWire
05.01.2026
MEDP
LISTED
NASDAQ
Medpace Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2025 Financial Results on February 9, 2026
News Preview
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its fourth quarter and fiscal year 2025 financial results after the market close on Monday, February 9, 2026. The Company will host a conference call the following morning, Tuesday, February 10, 2026, at 9:00 a.m. ET to discuss these results.
To participate in...
Themefolio
Profiler
Peergroup
© BusinessWire
05.01.2026
VIR
LISTED
NASDAQ
Vir Biotechnology to Present at the 44th Annual J.P. Morgan Healthcare Conference
News Preview
Vir Biotechnology, Inc. (Nasdaq: VIR), today announced that Marianne De Backer, M.Sc., Ph.D., MBA, Chief Executive Officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14 at 3:45 p.m. PT in San Francisco, California.
A live webcast of the presentation will be made available under Events & Presentat...
Themefolio
Profiler
Peergroup
© PR Newswire
05.01.2026
PGEN
LISTED
NASDAQ
Precigen to Present at the 44th Annual J.P. Morgan Healthcare Conference
News Preview
GERMANTOWN, Md., Jan. 5, 2026 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company advancing innovative precision medicines, today announced that Helen Sabzevari, PhD, President and Chief Executive Officer of Precigen, will present at the 44th Annual J.P. Morgan Healthcare Conference, taking place January 12–15, 2026 in San F...
Themefolio
Profiler
Peergroup
© PR Newswire
05.01.2026
VKTX
LISTED
NASDAQ
Viking Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
News Preview
SAN DIEGO, Jan. 5, 2026 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that its chief executive officer, Brian Lian, Ph.D., will deliver a corporate presentation at the 44th Annual J....
Themefolio
Profiler
Peergroup
© PR Newswire
05.01.2026
NBIX
LISTED
NASDAQ
Neurocrine Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
News Preview
SAN DIEGO, Jan. 5, 2026 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will present at the 44th Annual J.P. Morgan Healthcare Conference at 9:45 a.m. Pacific Time on Monday, January 12, 2026, in San Francisco. Kyle Gano, Chief Executive Officer, will present at the conference....
Themefolio
Profiler
Peergroup
© BusinessWire
05.01.2026
MCTA
LISTED
NASDAQ
Scott+Scott Attorneys at Law LLP Files Securities Class Action Against Charming Medical Limited (NASDAQ: MCTA)
News Preview
Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international securities and consumer rights litigation firm, today announced that it has filed a class action lawsuit against Defendants Charming Medical, Limited; Kit Wong; Ching Man Cheung; Josephine Yan Yeung; Leut Ming Gung; Shu Tai Victor Yu; Cathay Securities Inc.; WWC, P.C.; And Cogency...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.01.2026
ALMS
LISTED
NASDAQ
Alumis to Host Conference Call and Webcast to Report Phase 3 ONWARD Topline Data for Envudeucitinib in Moderate-to-Severe Plaque Psoriasis
News Preview
Alumis to Host Conference Call and Webcast to Report Phase 3 ONWARD Topline Data for Envudeucitinib in Moderate-to-Severe Plaque Psoriasis on Jan 6, 2026...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.01.2026
IART
LISTED
NASDAQ
Integra LifeSciences Leadership to Present at the 44th Annual J.P. Morgan Healthcare Conference
News Preview
PRINCETON, N.J., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that chief executive officer Mojdeh Poul and chief financial officer Lea Knight will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 a...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.01.2026
CMPX
LISTED
NASDAQ
Compass Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
BOSTON, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced it granted stock options to two new employees under the Company’s 2025 Inducement Plan and as a mater...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.01.2026
TDOC
LISTED
NYSE
Teladoc Health to Participate in Upcoming Investor Conference
News Preview
NEW YORK, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, announced today that Chuck Divita, chief executive officer, will participate in the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, January 12, 2026, at 3:45 p.m. PT (6:45 p.m. ET). A live audio webcast and r...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.01.2026
DRUG
LISTED
NASDAQ
Bright Minds to Announce Topline Results for BMB-101 Phase 2 Trial in Absence Seizures and Developmental and Epileptic Encephalopathies on Tuesday, January 6, 2026
News Preview
– Conference Call and Live Webcast at 8AM ET –...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.01.2026
OLMA
LISTED
NASDAQ
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.01.2026
TEVA
LISTED
TLV
Teva to Present at the 44th Annual J.P. Morgan Healthcare Conference
News Preview
TEL AVIV, Israel, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will present at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026. The presentation will begin at 8:15 A.M. Pacific Time (11:15 A.M. Eastern Time...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.01.2026
KALA
LISTED
NASDAQ
KALA BIO Settles Approximately $10.6 million of Debt
News Preview
ARLINGTON, Mass., Jan. 05, 2026 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), (“KALA” or the “Company”) today announced the successful completion of its loan settlement with Oxford Finance, LLC (“Oxford”), marking a transformational milestone for the Company. The completion of the settlement resolves critical debt obligations....
Themefolio
Profiler
Peergroup
© Globe Newswire
05.01.2026
JYNT
LISTED
NASDAQ
The Joint Corp. Appoints Ron Stilwell SVP Operations and Patient Experience
News Preview
Brings more than 30 Years of Operational Enhancement Success for Leading Franchisors Across Multiple Industries Brings more than 30 Years of Operational Enhancement Success for Leading Franchisors Across Multiple Industries...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.01.2026
AKBA
LISTED
NASDAQ
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
CAMBRIDGE, Mass., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted one newly-hired employee options to purchase an aggregate of 197,900 shares of Akebia’s common stock on December 31, 2025. The options were gr...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.01.2026
AVH
LISTED
ASX
AVITA Medical Announces Changes to its Board of Directors
News Preview
AVITA Medical appoints veteran medtech CEO Joe Woody to its Board as Lou Panaccio retires after more than a decade of service....
Themefolio
Profiler
Peergroup
© Globe Newswire
05.01.2026
FATE
LISTED
NASDAQ
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
News Preview
SAN DIEGO, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune diseases, today announced that on January 1, 2026, the Compa...
Themefolio
Profiler
Peergroup
© PR Newswire
05.01.2026
SEGN
LISTED
TSX
Seegnal's operating subsidiary Seegnal E-Health Ltd. hires AI VP to Strengthen AI Capabilities and Accelerates Development of Seegnal Guard
News Preview
/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/CALGARY, AB, Jan. 5, 2026 /CNW/ - Seegnal Inc. (TSXV: SEGN), a global leader in clinical decision support solutions applying patient-centric medication safety standards, today announced a major enhancement of its artificial intelligence capabilities with the...
Themefolio
Profiler
Peergroup
© BusinessWire
05.01.2026
INSP
LISTED
NYSE
FINAL DEADLINE REMINDER: Faruqi & Faruqi, LLP Reminds Inspire Medical Systems Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 5, 2026
News Preview
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Inspire Medical Systems, Inc. (“Inspire Medical” or the “Company”) (NYSE: INSP) and reminds investors of the January 5, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Com...
Themefolio
Profiler
Peergroup
© BusinessWire
05.01.2026
BAYN
LISTED
XETR
Bayer to Present Updates on Pharma Growth Strategy and Pipeline Advancements at J.P. Morgan’s 44th Annual Healthcare Conference
News Preview
Bayer will participate in the 44th J.P. Morgan Healthcare Conference 2026 taking place from January 12–15, 2026 in San Francisco. Stefan Oelrich, Member of the Board of Management, Bayer AG, and President of Bayer’s Pharmaceuticals Division, will present updates on the company’s pharmaceutical growth strategy and pipeline advancements across its p...
Themefolio
Profiler
Peergroup
© BusinessWire
05.01.2026
AGL
LISTED
NYSE
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of agilon health
News Preview
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against agilon health, inc. (“agilon” or the “Company”) (NYSE: AGL) and reminds investors of the March 2, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
This press rele...
Themefolio
Profiler
Peergroup
© EQS Newswire
05.01.2026
HBMN
LISTED
SIX
HBM Healthcare Investments once again delivered strong value growth in the 2025 calendar year despite currency headwind
News Preview
HBM Healthcare Investments, an investment company specialising in the healthcare sector, looks back on a successful 2025 calendar year. The net asset value (NAV) increased by 14.8 percent in Swiss francs (31.4 percent in US Dollars) over the course of the year, while the share price recorded a disproportionate gain of 33.0 percent.
In ......
Themefolio
Profiler
Peergroup
© Globe Newswire
05.01.2026
ALSAF
LISTED
EURONEXT
SAFE - DEMISSION DE RODOLPHE CADIO ET NOMINATION DE NICOLAS PAPILLON AU CONSEIL D'ADMINISTRATION
News Preview
DEMISSION DE RODOLPHE CADIO ET NOMINATION DE NICOLAS PAPILLON AU CONSEIL D'ADMINISTRATION...
Themefolio
Profiler
Peergroup
© Globe Newswire
05.01.2026
ZEAL
LISTED
CPH
Zealand Pharma to present at the J.P. Morgan Healthcare Conference
News Preview
Press release – No. 1 / 2026...
Themefolio
Profiler
Peergroup
© BusinessWire
05.01.2026
PFE
LISTED
NYSE
Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
News Preview
Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a discussion with Albert Bourla, Chairman and Chief Executive Officer, at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 at 9:45 a.m. PST.
To view and listen to the webcast, visit our web site at www.pfizer.com/inves...
Themefolio
Profiler
Peergroup
© PR Newswire
05.01.2026
1J5
LISTED
SES
Hyphens Pharma vergibt Lizenz für Cerapro® MED Hautbarrierecreme für sechs europäische Länder
News Preview
Cerapro® ist eine patentierte, den pH-Wert der Haut senkende Creme, die gemäß der Europäischen Medizinprodukteverordnung (CE-Kennzeichnung) für die Behandlung von atopischer Dermatitis zugelassen ist.Produkteinführung für 2026 in sechs europäischen Märkten geplant, darunter Schweiz, Österreich, Niederlande und Belgien. SINGAPUR, 5. Januar 2026 /P...
Themefolio
Profiler
Peergroup
© BusinessWire
05.01.2026
ALNY
LISTED
NASDAQ
Alnylam to Webcast Presentation at 44th Annual J.P. Morgan Healthcare Conference
News Preview
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will present a company overview and participate in a Q&A session at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 at 9:00 am PT (12:00 pm ET) at The Westin St. Francis in San Francisco. During the...
Themefolio
Profiler
Peergroup
© PR Newswire
05.01.2026
ABT
LISTED
NYSE
Abbott's new Libre Assist app feature tackles a top need for people living with diabetes: in-the-moment food decisions
News Preview
Traditional food logging apps offer feedback after the fact—Libre Assist1 offers help in-the-moment to inform mealtime decisions before every biteLibre Assist1 leverages AI to predict how food choices affect glucose levels,2 provides personalized meal guidance,3 and confirms glucose impact using data from Abbott's world-leading FreeStyle Libre con...
Themefolio
Profiler
Peergroup
© Newsfile
05.01.2026
TTI
LISTED
TSX
Thiogenesis to Present Clinical Updates in MELAS and Leigh Syndrome Spectrum at UMDF Bench-to-Bedside Webinar
News Preview
Dr. Rioux Will Present on Phase 2 MELAS Program & Upcoming Phase 2a Leigh Syndrome TrialSan Diego, California--(Newsfile Corp. - January 5, 2026) - Thiogenesis Therapeutics, Corp. (TSXV: TTI) (OTCQX: TTIPF) ("Thiogenesis" or the "Company"), a clinical-stage biotechnology company developing next-generation sulfur-based prodrugs for rare mitochondria...
Themefolio
Profiler
Peergroup
© PR Newswire
05.01.2026
DGX
LISTED
NYSE
Corewell Health and Quest Diagnostics Complete Laboratory Joint Venture Transaction in Michigan
News Preview
Quest also now provides comprehensive Collaborative Lab Solutions (Co-Lab) hospital lab management services for all 21 Corewell Health hospitals SOUTHFIELD, Mich. and GRAND RAPIDS, Mich. and SECAUCUS, N.J., Jan. 5, 2026 /PRNewswire/ -- Corewell Health and Quest Diagnostics (NYSE: DGX) today announced the completion of the previously announced tran...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
